They showed that interfering with collagen crosslinking into fibers by inhibition of the lysyl oxidase (LOX) enzyme reduces ECM content and tumor stiffness, improving T cell migration and improving the efficacy of anti-PD-1 blockade. Here, LOX is linked to neoplasm.